BridgeBio Oncology Therapeutics, Inc. (BBOT)

NASDAQ: BBOT · Real-Time Price · USD

4.770

-0.120 (-2.45%)

At close: Sep 18, 2026, 4:00 PM EDT

4.834

+0.064 (1.34%)

After-hours: Sep 18, 2026, 7:30 PM EDT

BBOT Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Cash & Equivalents	54.06	373.69	30.85	0.25
Short-Term Investments	171.65	51.77	124.78	-
Cash & Short-Term Investments	225.71	425.46	155.63	0.25
Cash Growth	71.78%	173.38%	62152.40%	-
Other Receivables	0.66	0.39	0.08	1.72
Receivables	0.66	0.39	0.08	1.72
Prepaid Expenses	16.01	6.55	2.98	1.96
Total Current Assets	242.38	432.4	158.69	3.94
Property, Plant & Equipment	2.98	3.29	0.49	0.6
Other Long-Term Assets	12.93	12.7	5.12	1.41
Total Assets	376.71	448.38	164.3	5.94

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Accounts Payable	6.73	1.37	3.07	0.58
Accrued Expenses	43.37	32.61	12.92	3.54
Current Portion of Leases	0.55	0.52	-	-
Other Current Liabilities	0.99	0.53	3.59	12.66
Total Current Liabilities	51.63	35.04	19.58	16.78
Long-Term Leases	1.96	2.24	-	-
Total Liabilities	53.59	37.29	19.58	16.78

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Common Stock	0.01	0.01	-	-
Additional Paid-In Capital	779.19	767.64	43.54	32.61
Retained Earnings	-455.13	-356.57	-222.52	-148.25
Comprehensive Income & Other	-0.96	0.02	0.35	-
Total Common Equity	323.11	411.1	-178.64	-115.64
Shareholders' Equity	323.11	411.1	144.72	-10.83
Total Liabilities & Equity	376.71	448.38	164.3	5.94

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Total Debt	2.51	2.77	-	-
Net Cash (Debt)	341.62	422.69	155.63	0.25
Net Cash Growth	165.72%	171.60%	62152.40%	-
Net Cash Per Share	4.80	13.57	12061.61	2.00
Filing Date Shares Outstanding	80.17	80.03	0.32	0.12
Total Common Shares Outstanding	80.12	79.99	0.32	0.12
Working Capital	190.74	397.36	139.11	-12.84
Book Value Per Share	4.03	5.14	-558.92	-927.16
Tangible Book Value	323.11	411.1	-178.64	-115.64
Tangible Book Value Per Share	4.03	5.14	-558.92	-927.16